To be noted, RV counteracted the IL-6-induced proliferation in three different ovarian cancer cell lines, suggesting that the mechanism involved is independent of the genetic background of oncogenes and oncosuppressors. The gene discussed is IL6; the disease is ovarian carcinoma.